Reviewing Medifast (NYSE:MED) and Honest (NASDAQ:HNST)

Medifast (NYSE:MED – Get Free Report) and Honest (NASDAQ:HNST – Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, analyst recommendations, earnings, valuation and risk.

Institutional & Insider Ownership

95.5% of Medifast shares are held by institutional investors. Comparatively, 45.5% of Honest shares are held by institutional investors. 3.7% of Medifast shares are held by company insiders. Comparatively, 9.4% of Honest shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Risk & Volatility

Medifast has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Honest has a beta of 2.48, meaning that its share price is 148% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for Medifast and Honest, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medifast 1 2 0 0 1.67
Honest 1 4 2 2 2.56

Medifast currently has a consensus price target of $12.00, indicating a potential downside of 1.83%. Honest has a consensus price target of $5.42, indicating a potential upside of 15.92%. Given Honest’s stronger consensus rating and higher probable upside, analysts clearly believe Honest is more favorable than Medifast.

Valuation & Earnings

This table compares Medifast and Honest”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Medifast $385.79 million 0.35 -$18.67 million ($3.69) -3.31
Honest $371.32 million 1.37 -$15.69 million $0.69 6.78

Honest has lower revenue, but higher earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Honest, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Medifast and Honest’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Medifast -13.64% -6.90% -5.34%
Honest 23.47% 5.10% 4.03%

Summary

Honest beats Medifast on 13 of the 15 factors compared between the two stocks.

About Medifast

(Get Free Report)

Medifast, Inc. is a health and wellness company focused on weight management and healthy living. Its products and programs are marketed primarily under the OPTAVIA brand. OPTAVIA offers structured plans that combine portion-controlled meal replacements and other nutrition products with guidance from independent coaches. The company’s approach emphasizes nutrition, behavior changes and ongoing support. Founded in 1980, Medifast serves customers primarily in the United States. Its business centers on selling products and connecting customers with coaches who provide support as they follow the company’s programs.

About Honest

(Get Free Report)

The Honest Company, founded in 2011 by Jessica Alba and entrepreneur Brian Lee, develops consumer products for families with an emphasis on ingredient transparency and thoughtfully designed everyday essentials. The company is headquartered in Los Angeles, California. Its products include disposable diapers and wipes, baby and personal-care items, and household cleaning products. Honest sells through its website and retail partners, serving customers primarily in the United States and Canada. Carla VernĂ³n became the company’s chief executive officer in 2023.

Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.